Adel Zamri

Prof. Adel Zamri

Universitas Riau
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Tetrahedron
Verified
Journal Article
Closed access
AZAdel Zamri
Adel Zamri
MAMohamed A Abdallah
Mohamed A Abdallah

1 November 2019 in Advances and Applications in Bioinformatics and Chemistry
Verified
Journal Article
Open access
PDF file
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
MYMuhammad Yusuf
Muhammad Yusuf
HSHasna Nur Syahidah
Hasna Nur Syahidah
ASAnas Subarnas
Anas Subarnas
AZAdel Zamri
Adel Zamri
TLThierry Langer
Thierry Langer
Background: The 2ʹ,4ʹ-dihydroxy-6-methoxy-3,5-3-dimethylchalcone (ChalcEA) isolated from Eugenia aquea Burm f. leaves has potential anticancer activity against human breast-adenocarcinoma cell lines (MCF-7) with an IC50 value of 250 μM. However, its apoptotic activity on the T47D breast cancer cell lines which is involving caspase-3 has not been investigated. Materials and methods: Therefore, this study aims to evaluate the cytotoxicity of ChalcEA on the T47D cell lines using the 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST) method and to predict its possible antagonistic activity on the human estrogen receptor alpha (hERα) using pharmacophore and molecular dynamics (MD) methods. The in vitro test of 10 synthesized ChalcEA derivatives was also performed as an insight into the further development of its structure as an anticancer agent. Results: It is shown that ChalcEA has an IC50 of 142.58 ± 4.6 μM against the hERα-overexpressed T47D breast cancer cell lines, indicating its possible mechanism of anticancer activity as an antagonist of hERα. Pharmacophore study showed that ChalcEA shares similar features with the known hERα antagonist, 4-hydroxytamoxifen (4-OHT), which has hydrogen bond donor (HBD), hydrogen bond acceptor (HBA), ring aromaticity (RA), and hydrophobicity (Hy) features. Molecular docking showed that ChalcEA formed hydrogen bonds with Glu353 and Arg394, and hydrophobic interactions in a similar manner with 4-OHT. Moreover, MD simulations showed that ChalcEA destabilized the conformation of His524, a remarkable behavior of a known hERa antagonist, including 4-OHT. Furthermore, the 10 best chalcone derivatives resulted from pharmacophore- and docking-based screening, were tested against the T47D cell lines. None of the derivatives have better activity than ChalcEA. It is suggested that the functional groups at the B-ring of ChalcEA are interesting to be further optimized in the next studies. Conclusion: ChalcEA might act as an antagonist toward hERα, thus warranting further investigation as a potential anticancer agent.

1 March 2003 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
AZAdel Zamri
Adel Zamri
ISI.J Schalk
I.J Schalk
FPF Pattus
F Pattus
MAM.A Abdallah
M.A Abdallah

1 April 1999 in Tetrahedron
Verified
Journal Article
Closed access
AZAdel Zamri
Adel Zamri
FSFinton Sirockin
Finton Sirockin
MAMohamed A. Abdallah
Mohamed A. Abdallah

1 April 2020 in Pharmacology and Clinical Pharmacy Research
Verified
Journal Article
Open access
PDF file
RHRomi Habibi
Romi Habibi
Noval HerfindoNoval Herfindo
Noval Herfindo
RHRudi Hendra
Rudi Hendra
Hilwan TerunaHilwan Teruna
Hilwan Teruna
AZAdel Zamri
Adel Zamri
Curcumin is a secondary metabolite compound that has diverse biological activities. However, it is easily hydrolyzed at physiological pH due to the presence of the β-diketone group. Therefore, the replacement of the β-diketone group with mono ketone is expected to overcome this issue. We hereby report the synthesis of mono ketone curcumin derivatives from piperidone by two-steps reactions. The synthesis of curcumin derivate 3 was carried out by Claisen-Schmidt condensation between 4-piperidone and 4-methoxybenzaldehyde using alkaline catalyst. The synthesized curcumin derivate 3 was then reacted with the 1-bromo-3-chloropropane to produce curcumin derivate 5, 1-(3-chloropropyl)-3.5-bis((E)-4-methoxybenzylidene)piperidin-4-one, with 72% yield. The calculated docking scores, the curcumin derivate 5 possessed a better affinity for receptors than the standard panduratin A. The curcumin derivate 5 has a lower docking score of -6.40 kcal/mol compared to panduratin A with value of -5.18 kcal/mol and also had strong binding interactions to DEN2 NS2B/NS3 protease. Thus, this compound is promising candidate as a new anti-dengue agent.

28 November 2016 in Molekul
Verified
Journal Article
Open access
PDF file
AZAdel Zamri
Adel Zamri
Hilwan TerunaHilwan Teruna
Hilwan Teruna
IIIhsan Ikhtiarudin
Ihsan Ikhtiarudin
Some 2’-hydroxychalcone analogues have been widely used as an intermediate to synthesize various heterocyclic compounds, such as flavanones, flavanonols, flavones, flavonols and others. The heterocyclic compounds are also known to have a variety of interesting bioactivities in the medicinal chemistry and also have potency to be applied in material chemistry including in industry. Therefore, 2’-hydroxychalcone analogues are often synthesized by researchers as intermediate, both in research associated with drug discovery and material synthesis. The aim of this study is to investigate the effect of microwave irradiation power variations on the selectivity of reaction of 2’-hydroxychalcone analogue synthesis. The variations of power that have been used in this study were 100, 180, 300 and 450 W with using a domestic microwave. Based on the study, we conclude that the power variation of microwave irradiationwere proven to effect the selectivity of synthesis reaction. In this study, the most suitable irradiation power to be applied on this synthesis is 180 W.